Covaxin News

Brazil to suspend $324 million Covaxin deal with Bharat Biotech amid probe

Brazil to suspend $324 million Covaxin deal with Bharat Biotech amid probe

Brazil will suspend a $324 million Indian vaccine contract that has mired President Jair Bolsonaro in accusations of irregularities, the health minister said on Tuesday, following the guidance of the federal comptroller, the CGU. The deal to buy 20 million doses of Bharat Biotech’s Covaxin shot has become a headache

WHO accepts expression of interest for ‘Covaxin’ emergency use listing

WHO accepts expression of interest for ‘Covaxin’ emergency use listing

Hyderabad: After the vaccine manufacturer Bharat Biotech provided additional data sought by World Health Organization (WHO), Covaxin has inched a step closer to WHO’s emergency use listing (EUL) with the global body accepting manufacturer’s expression of interest (EoI) for the inactivated vaccine. The pre-submission meeting of the Indian vaccine maker with WHO

Bharat Biotech expects WHO nod for emergency use of Covaxin within 2-4 months

Bharat Biotech expects WHO nod for emergency use of Covaxin within 2-4 months

New Delhi: As countries prep to gradually restart travel and tourism after prolonged Covid restrictions, there is nervousness among students about the World Health Organisation and many countries not listing Bharat Biotech’s Covaxin among approved vaccines. The US, Canada, Australia, Ireland and the EU are among those do not have

Hester Biosciences in talks with Bharat Biotech for tech transfer of ‘Covaxin’

Hester Biosciences in talks with Bharat Biotech for tech transfer of ‘Covaxin’

New Delhi: Hester Biosciences is reportedly in discussions with Bharat Biotech for technology transfer to produce ‘Covaxin’ is underway. Ahmedabad-based Hester is into animal and poultry vaccines. “A triparty consortium has been formed with the Government of Gujarat as the lead partner, to explore the prospects of manufacturing the Covid vaccine

Covaxin effective against double mutant strain of SARS-CoV-2: ICMR study

Covaxin effective against double mutant strain of SARS-CoV-2: ICMR study

New Delhi: Bharat Biotech’s Covid19 vaccine ‘covaxin’ reportedly neutralises multiple variants of coronavirus and has been effective against the double mutant strain- B.1.617, of SARS-CoV-2 and other variants as well, an Indian Council of Medical Research (ICMR) study said on Wednesday. “#COVAXIN neutralises against multiple variants of SARS-CoV-2 and effectively